Zobrazeno 1 - 2
of 2
pro vyhledávání: '"monarchE Committee Members"'
Autor:
Rugo, H S, O'Shaughnessy, J, Boyle, F, Toi, M, Broom, R, Blancas, I, Gumus, M, Yamashita, T, Im, Y-H, Rastogi, P, Zagouri, F, Song, C, Campone, M, San Antonio, B, Shahir, A, Hulstijn, M, Brown, J, Zimmermann, A, Wei, R, Johnston, S R D, Reinisch, M, Tolaney, S M, monarchE Committee Members
In monarchE, abemaciclib plus endocrine therapy (ET) as adjuvant treatment of hormone receptor-positive, human epidermal growth factor 2-negative, high-risk, early breast cancer (EBC) demonstrated a clinically meaningful improvement in invasive disea
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::22ea3fc147217fa7dcbcf43082a19eef
https://hdl.handle.net/10668/21896
https://hdl.handle.net/10668/21896
BACKGROUND: In monarchE, abemaciclib plus endocrine therapy (ET) as adjuvant treatment of hormone receptor-positive, human epidermal growth factor 2-negative, high-risk, early breast cancer (EBC) demonstrated a clinically meaningful improvement in in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2127::289b7b1ac47ba703c525e0b15a221484
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3219290
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3219290